Shay Capital’s Abivax ABVX Stock Holding History

Shay Capital’s Portfolio ABVX Stock Details ABVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-52,829	Closed	-$330K	–	315
2025 Q1	$330K	Buy	52,829 +2,800	+6%	+$18.9K	0.05%	187
2024 Q4	$366K	Buy	+50,029	New	+$461K	0.06%	210

Other funds holding ABVX

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Shay Capital's ABVX Position: Q2 2025 in Review

Shay Capital sold out of Abivax (ABVX) in Q2 2025, closing a stake of 52,829 shares — an estimated $330K sold.

Shay Capital first reported a position in ABVX in Q4 2024 and held it in 2 quarters. The position peaked at $366K in Q4 2024. 43 funds tracked by Wall St. Rank hold ABVX as of Q2 2025.

Shay Capital reported no remaining Abivax position as of Q2 2025 after selling out during the quarter.
Shay Capital sold 52,829 Abivax shares in Q2 2025, an estimated $330K.
Shay Capital first reported a position in Abivax in Q4 2024 and held it in 2 quarters.
Shay Capital's Abivax position peaked at $366K in Q4 2024.
43 funds tracked by Wall St. Rank held Abivax as of Q2 2025.

Based on Shay Capital's 13F filing for Q2 2025, filed 14 Aug 2025.